Argentiere Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-42,000
| Closed | -$3.73M | – | 3 |
|
|
2019
Q1 | $3.73M | Sell |
42,000
-1,000
| -2% | -$88.8K | 1.62% | 5 |
|
|
2018
Q4 | $3.66M | Buy |
43,000
+3,800
| +10% | +$324K | 1.14% | 8 |
|
|
2018
Q3 | $3.8M | Buy |
39,200
+4,200
| +12% | +$407K | 0.39% | 11 |
|
|
2018
Q2 | $3.3M | Sell |
35,000
-35,000
| -50% | -$3.3M | 1.27% | 16 |
|
|
2018
Q1 | $5.68M | Buy |
70,000
+20,000
| +40% | +$1.62M | 2.42% | 8 |
|
|
2017
Q4 | $4.46M | Buy |
50,000
+5,000
| +11% | +$446K | 2.75% | 6 |
|
|
2017
Q3 | $4.19M | Buy |
45,000
+2,000
| +5% | +$186K | 1.61% | 14 |
|
|
2017
Q2 | $3.91M | Buy |
43,000
+2,000
| +5% | +$182K | 1.31% | 12 |
|
|
2017
Q1 | $3.6M | Buy |
41,000
+10,000
| +32% | +$878K | 1.45% | 14 |
|
|
2016
Q4 | $2.57M | Buy |
+31,000
| New | +$2.57M | 1.21% | 18 |
|
|
2014
Q4 | – | Sell |
-22,400
| Closed | -$1.62M | – | 22 |
|
|
2014
Q3 | $1.62M | Hold |
22,400
| – | – | 0.72% | 10 |
|
|
2014
Q2 | $1.39M | Buy |
+22,400
| New | +$1.39M | 0.63% | 11 |
|